Contraception
Volume 79, Issue 4 , Pages 282-289, April 2009

Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate

Received 30 April 2008; received in revised form 20 October 2008; accepted 20 October 2008. published online 17 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was funded by Schering (Berlin, Germany; now Bayer Schering Pharma).

PII: S0010-7824(08)00491-5

doi:10.1016/j.contraception.2008.10.010

Contraception
Volume 79, Issue 4 , Pages 282-289, April 2009